Role of cytomegalovirus (CMV)-specific polyfunctional CD8+ T-cells and antibodies neutralizing virus epithelial infection in the control of CMV infection in an allogeneic stem-cell transplantation setting

Journal of General Virology

Volumn 96, Issue 9, 2015, Pages 2822-2831

  Giménez, Estela ^a   Blanco Lobo, Pilar ^b   Muñoz Cobo, Beatriz ^a   Solano, Carlos ^a   Amat, Paula ^a   Pérez Romero, Pilar ^b   Navarro, David ^a,c  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIBODY;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EPITHELIUM CELL; FEMALE; HUMAN; HUMORAL IMMUNITY; MALE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; VIRUS REPLICATION; ADVERSE EFFECTS; ALLOTRANSPLANTATION; CYTOMEGALOVIRUS INFECTIONS; EPITHELIUM; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; VIREMIA; VIROLOGY;

ADULT; AGED; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPITHELIUM; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; VIREMIA;

EID: 84941584797     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.000203     Document Type: Article

References (37)

1. Boeckh, M., Murphy, W. J. & Peggs, K. S. (2015). Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies. Biol Blood Marrow Transplant 21, 24–29.
2. Chemaly, R. F., Ullmann, A. J., Stoelben, S., Richard, M. P., Bornhäuser, M., Groth, C., Einsele, H., Silverman, M., Mullane, K. M. & other authors (2014). Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. N Engl J Med 370, 1781–1789.
3. Clari, M. A., Bravo, D., Costa, E., Muñoz-Cobo, B., Solano, C., Remigia, M. J., Giménez, E., Benmarzouk-Hidalgo, O. J., Pérez- Romero, P. & Navarro, D. (2013). Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemia. Diagn Microbiol Infect Dis 75, 207–209.
4. Cui, X., Meza, B. P., Adler, S. P. & McVoy, M. A. (2008). Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection. Vaccine 26, 5760–5766.
5. Forster, M. R., Trgovcich, J., Zimmerman, P., Chang, A., Miller, C., Klenerman, P. & Cook, C. H. (2010). Antiviral prevention of sepsis induced cytomegalovirus reactivation in immunocompetent mice. Antiviral Res 85, 496–503.
6. +T cells. J Gen Virol 86, 275–284.
7. Giménez, E., Muñoz-Cobo, B., Solano, C., Amat, P., Navarro, D. & Tang, Y.-W. (2014). Early kinetics of plasma cytomegalovirus DNA load in allogeneic stem cell transplant recipients in the era of highly sensitive real-time PCR assays: does it have any clinical value? J Clin Microbiol 52, 654–656.
8. Gimeno, C., Solano, C., Latorre, J. C., Hernández-Boluda, J. C., Clari, M. A., Remigia, M. J., Furio´, S., Calabuig, M., Tormo, N. & Navarro, D. (2008). Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients. J Clin Microbiol 46, 3311–3318.
9. Guglielmo, B. J., Wong-Beringer, A. & Linker, C. A. (1994). Immune globulin therapy in allogeneic bone marrow transplant: a critical review. Bone Marrow Transplant 13, 499–510.
10. Hahn, G., Jarosch, M., Wang, J. B., Berbes, C. & McVoy, M. A. (2003). Tn7-mediated introduction of DNA sequences into bacmid-cloned cytomegalovirus genomes for rapid recombinant virus construction. J Virol Methods 107, 185–194.
11. Hahn, G., Revello, M. G., Patrone, M., Percivalle, E., Campanini, G., Sarasini, A., Wagner, M., Gallina, A., Milanesi, G. & other authors (2004). Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 78, 10023–10033.
12. Harari, A., Dutoit, V., Cellerai, C., Bart, P. A., Du Pasquier, R. A. & Pantaleo, G. (2006). Functional signatures of protective antiviral Tcell immunity in human virus infections. Immunol Rev 211, 236–254.
13. Klenovsek, K., Weisel, F., Schneider, A., Appelt, U., Jonjic, S., Messerle, M., Bradel-Tretheway, B., Winkler, T. H. & Mach, M. (2007). Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells. Blood 110, 3472–3479.
14. Król, L., Stuchlý, J., Hubáček, P., Keslová, P., Sedláček, P., Starý, J., Hrušák, O. & Kalina, T. (2011). Signature profiles of CMV-specific Tcells in patients with CMV reactivation after hematopoietic SCT. Bone Marrow Transplant 46, 1089–1098.
15. Lacey, S. F., La Rosa, C., Zhou, W., Sharma, M. C., Martinez, J., Krishnan, A., Gallez-Hawkins, G., Thao, L., Longmate, J. & other authors (2006). Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients. J Infect Dis 194, 1410–1421.
16. +T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection. Haematologica 93, 248–256.
17. Lilleri, D., Kabanova, A., Lanzavecchia, A. & Gerna, G. (2012). Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo. J Clin Immunol 32, 1324–1331.
18. Lilleri, D., Kabanova, A., Revello, M. G., Percivalle, E., Sarasini, A., Genini, E., Sallusto, F., Lanzavecchia, A., Corti, D. & Gerna, G. (2013). Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection. PLoS One 8, e59863.
19. Macagno, A., Bernasconi, N. L., Vanzetta, F., Dander, E., Sarasini, A., Revello, M. G., Gerna, G., Sallusto, F. & Lanzavecchia, A. (2010). Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex. J Virol 84, 1005–1013.
20. Maidji, E., McDonagh, S., Genbacev, O., Tabata, T. & Pereira, L. (2006). Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis. Am J Pathol 168, 1210–1226.
21. Muñoz, I., Gutiérrez, A., Gimeno, C., Farga, A., Alberola, J., Solano, C., Prósper, F., García-Conde, J. & Navarro, D. (2001). Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant. J Med Virol 65, 77–84.
22. + NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients. J Med Virol 84, 259–267.
23. Reddehase, M. J., Balthesen, M., Rapp, M., Jonjić, S., Pavić, I. & Koszinowski, U. H. (1994). The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J Exp Med 179, 185–193.
24. Ryckman, B. J., Chase, M. C. & Johnson, D. C. (2008a). HCMV gH/ gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors. Proc Natl Acad Sci U S A 105, 14118–14123.
25. Ryckman, B. J., Rainish, B. L., Chase, M. C., Borton, J. A., Nelson, J. A., Jarvis, M. A. & Johnson, D. C. (2008b). Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J Virol 82, 60–70.
26. Schoppel, K., Schmidt, C., Einsele, H., Hebart, H. & Mach, M. (1998). Kinetics of the antibody response against human cytomegalovirusspecific proteins in allogeneic bone marrow transplant recipients. J Infect Dis 178, 1233–1243.
27. Solano, C. & Navarro, D. (2010). Clinical virology of cytomegalovirus infection following hematopoietic transplantation. Future Virol 5, 111–124.
28. +T cells early after allogeneic stem cell transplantation may identify patients at risk of active cytomegalovirus infection. Haematologica 93, 1434–1436.
29. +T cells is associated with rising levels of pp65 antigenemia and DNAemia during preemptive therapy in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 45, 543–549.
30. +T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection. J Med Virol 82, 1208–1215.
31. +T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT. Bone Marrow Transplant 46, 1437–1443.
32. Vanarsdall, A. L., Ryckman, B. J., Chase, M. C. & Johnson, D. C. (2008). Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans. J Virol 82, 11837–11850.
33. Volpi, A., Pica, F., Gentile, G., Capobianchi, A., Fraschetti, M. & Martino, P. (1999). Neutralizing antibody response against human cytomegalovirus in allogeneic bone marrow-transplant recipients. J Infect Dis 180, 1747–1748.
34. Wang, D. & Shenk, T. (2005a). Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc Natl Acad Sci U S A 102, 18153–18158.
35. Wang, D. & Shenk, T. (2005b). Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. J Virol 79, 10330–10338.
36. Yamazaki, R., Tanaka, Y., Nakasone, H., Sato, M., Terasako-Saito, K., Sakamoto, K., Akahoshi, Y., Nakano, H., Ugai, T. & other authors (2014). Allotype analysis to determine the origin of cytomegalovirus immunoglobulin-G after allogeneic stem cell transplantation. Transpl Infect Dis 16, 904–913.
37. Zhou, W., Longmate, J., Lacey, S. F., Palmer, J. M., Gallez-Hawkins, G., Thao, L., Spielberger, R., Nakamura, R., Forman, S. J. & other authors (2009). Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMVpositive transplant recipients. Blood 113, 6465–6476.